WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011134669) METHODS FOR INDUCING AN IMMUNE RESPONSE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/134669    International Application No.:    PCT/EP2011/002153
Publication Date: 03.11.2011 International Filing Date: 29.04.2011
IPC:
A61K 47/48 (2006.01), A61P 37/04 (2006.01)
Applicants: TELORMEDIX SA [CH/CH]; Via della Posta 10 CH-6934 Bioggio (CH) (For All Designated States Except US).
BARBERIS, Alcide [CH/CH]; (CH) (For US Only).
PATTARINO, Franco [IT/IT]; (IT) (For US Only).
MURA, Emanuela [IT/CH]; (CH) (For US Only).
MAJ, Roberto [IT/CH]; (CH) (For US Only)
Inventors: BARBERIS, Alcide; (CH).
PATTARINO, Franco; (IT).
MURA, Emanuela; (CH).
MAJ, Roberto; (CH)
Agent: GRAF VON STOSCH, Andreas; Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München (DE)
Priority Data:
61/330,119 30.04.2010 US
Title (EN) METHODS FOR INDUCING AN IMMUNE RESPONSE
(FR) PROCÉDÉS D'INDUCTION D'UNE RÉPONSE IMMUNITAIRE
Abstract: front page image
(EN)Provided in some embodiments are methods for inducing an antigen-specific immune response in a subject, comprising administering a compound having a structure according to Formula A or Formula B: or a pharmaceutically acceptable salt, tautomer or hydrate thereof, where X2 is a bond or linker, X3 is -P04-, and X1, R1, R2, R3, and n are described herein. Also provided in some embodiments are methods for making and using such compounds and compositions.
(FR)L'invention concerne, dans certains modes de réalisation, des procédés d'induction d'une réponse immunitaire spécifique de l'antigène chez un sujet. Ces procédés comprennent l'administration d'un composé ayant une structure selon la Formule A ou la Formule B : ou un sel pharmaceutiquement acceptable, un tautomère ou un hydrate de celui-ci, où X2 est une liaison ou une fraction de liaison, X3 est -PO4-, et X1, R1, R2, R3 et n sont tels que décrits ici. L'invention concerne également, dans certains modes de réalisation, des procédés de fabrication et d'utilisation de tels composés et de telles compositions.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)